PECR catalyzes the reduction of trans-2-enoyl-CoA to acyl-CoA during fatty acid elongation cycles. Each cycle adds two carbons to fatty acid chains, critical for synthesizing VLCFAs . Key functions include:
Fatty Acid Biosynthesis: Essential for converting dietary phytol into phytanic acid .
Metabolic Pathways:
miRNA Interaction: Bovine miR-124a directly targets PECR’s 3′-UTR, reducing its expression and altering lipid synthesis in mammary cells .
Gut Microbiome: Clostridium bolteae encodes a homolog (97.7% identity) that metabolizes ketone-containing xenobiotics, suggesting evolutionary conservation of PECR’s reductase function .
Study | Model System | Key Insight |
---|---|---|
Bovine miR-124a (2019) | MAC-T bovine cells | miR-124a inversely regulates PECR expression |
Microbial Homologs (2024) | Clostridium bolteae | Split homologs metabolize steroids |
Disease Associations:
Drug Metabolism: Microbial PECR homologs may contribute to xenobiotic processing, though human PECR itself has no known drug interactions .
Pathway | Role of PECR |
---|---|
Fatty Acid Elongation | Catalyzes final reduction step |
Phytol Degradation | Converts phytol to phytanic acid |
Functional Studies: Limited data on PECR’s role in human diseases.
Therapeutic Potential: Targeting PECR could modulate lipid profiles in metabolic disorders.
Microbiome Interactions: Microbial homologs may explain interindividual drug response variability .
PECR is a critical yet understudied enzyme in lipid metabolism, with emerging roles in both endogenous fatty acid synthesis and microbial xenobiotic processing. Further research is needed to explore its therapeutic potential and mechanistic nuances.
PECR (Peroxisomal trans-2-enoyl-CoA reductase) is a metabolic enzyme involved in fatty acid metabolism. It functions in the peroxisomal fatty acid oxidation pathway, specifically in the reduction of unsaturated enoyl-CoAs. The human PECR gene maps to chromosome 2q35 . The protein contains 303 amino acids with a molecular mass of approximately 35.1 kDa when expressed recombinantly . PECR plays a critical role in the metabolism of branched-chain fatty acids and certain unsaturated fatty acids that cannot be processed by the mitochondrial β-oxidation system.
Human PECR is a single polypeptide chain containing 303 amino acids in its native form. When expressed recombinantly, it can be produced as a non-glycosylated protein with a His-tag fusion at the N-terminus, resulting in a total length of 327 amino acids . The molecular mass of the recombinant His-tagged protein is approximately 35.1 kDa . The protein functions within peroxisomes, where it catalyzes reduction reactions in fatty acid metabolism pathways. Its structure contains NAD(P)H-binding domains typical of reductase enzymes in this family.
The regulation of PECR gene expression involves multiple mechanisms that respond to cellular metabolic states. While the search results don't provide specific details on PECR regulation, modern gene activation technologies like CRISPR activation systems can be used to study its expression. These systems utilize a deactivated Cas9 (dCas9) fused to activation domains like VP64, coupled with target-specific sgRNAs engineered to bind transcription activators . This synergistic activation mediator (SAM) transcription activation system can maximize the activation of endogenous PECR gene expression . Natural regulation likely involves metabolic sensing pathways that detect lipid levels and oxidative states within cells.
Several research tools are available for studying human PECR:
PECR Lentiviral Activation Particles: These utilize a SAM transcription activation system with deactivated Cas9 (dCas9) nuclease fused to VP64 activation domain, along with sgRNA (MS2) engineered to bind MS2-P65-HSF1 fusion protein . This system allows specific upregulation of PECR gene expression.
Recombinant PECR Protein: Human PECR recombinant protein produced in E. coli is available as a single, non-glycosylated polypeptide chain containing 327 amino acids (including a 24-amino acid His-tag at the N-terminus) . This can be used for in vitro enzyme assays or as standards in detection methods.
PECR ELISA Kits: These kits are designed to detect native (not recombinant) PECR in appropriate sample types including undiluted body fluids and/or tissue homogenates . They provide quantitative measurement of PECR levels.
For recombinant PECR protein, the following storage recommendations apply:
Storage Duration | Recommended Temperature | Additional Recommendations |
---|---|---|
Short-term (2-4 weeks) | 4°C | If entire vial will be used |
Long-term | -20°C | For longer periods of time |
Extended storage | -20°C | Add carrier protein (0.1% HSA or BSA) |
Multiple freeze-thaw cycles should be avoided to maintain protein integrity . For shipping, cool pack conditions are recommended . These conditions help maintain the structural and functional integrity of the protein for research applications.
When studying PECR function in rare metabolic disorders using a single-case experimental design, consider the following methodological approach:
Baseline Phase Establishment: Collect representative baseline data to serve as a comparison for subsequent intervention phases. Ensure multiple measurements during this phase to establish stability .
Experimental Control Implementation: Use within-subject comparison rather than between-subjects design. The participant provides their own control data, with replication of effects either within or between participants to establish experimental control .
Randomization Component: To improve methodological rigor and internal validity, incorporate randomization elements as suggested by Kratochwill and Levin (2010) .
Repeated Systematic Assessment: Measure dependent variables (e.g., metabolite levels, clinical symptoms) repeatedly across and within all conditions or phases of the independent variable (e.g., intervention targeting PECR function) .
Data Analysis Approach: Consider both visual analysis and statistical approaches. Recent SCED research shows discord regarding analytic methods, so clearly justify your chosen approach .
This methodological framework is particularly valuable for studying rare conditions where large sample sizes are impractical, allowing for rigorous assessment of interventions targeting PECR function.
CRISPR-based technologies offer powerful approaches for studying PECR gene function:
Gene Activation (CRISPRa): PECR Lentiviral Activation Particles utilize a synergistic activation mediator (SAM) transcription activation system incorporating deactivated Cas9 (dCas9-D10A and N863A) fused to VP64 activation domain . This system works with sgRNA (MS2) engineered to bind the MS2-P65-HSF1 fusion protein, maximizing endogenous PECR gene expression . This approach enables studying the effects of PECR upregulation on cellular metabolism and function.
Gene Knockout (CRISPRko): Although not specifically mentioned in the search results for PECR, CRISPR-Cas9 systems can be adapted for gene knockout studies as noted in references 1 and 2 of the first search result . This would involve designing guide RNAs targeting exonic regions of PECR to induce frameshift mutations.
Precision Editing: For studying specific variants or domains, precision editing can be performed to introduce point mutations or domain modifications to assess functional consequences on enzyme activity.
Temporal Control: Inducible CRISPR systems can provide temporal control over gene modification, allowing researchers to study PECR function at specific developmental stages or under particular metabolic conditions.
These approaches enable comprehensive functional characterization of PECR and its role in peroxisomal fatty acid metabolism.
Analyzing large-scale data from PECR expression studies presents several challenges that can be addressed through advanced computational approaches:
Big Qualitative Data Handling: Large datasets containing qualitative information about PECR expression patterns across different tissues or conditions require specialized Big Qualitative (Big Qual) methods to efficiently extract meaningful insights .
Integration of AI and Human Analysis: A combined approach of artificial intelligence methods and human expertise offers the most effective strategy. While machine learning significantly reduces analysis time, human input remains crucial for refining categories and capturing nuances in expression data .
Natural Language Processing Applications: For analyzing literature and text-based data about PECR, NLP combined with machine learning can identify patterns and connections that might be missed in manual reviews .
Sentiment and Thematic Analysis: When examining functional implications of PECR expression changes, combining NLP and machine learning with human input allows for nuanced interpretation of complex data relationships .
Time and Resource Management: Machine-assisted analysis can significantly reduce processing time for large datasets while maintaining analytical depth when properly combined with expert human oversight .
This hybrid approach to data analysis enables researchers to efficiently process large PECR expression datasets while preserving the nuance and complexity necessary for meaningful biological interpretation.
Designing experiments to investigate PECR interactions with other fatty acid metabolism enzymes requires a multi-faceted approach:
Protein-Protein Interaction Studies:
Co-immunoprecipitation (Co-IP) using antibodies against native PECR to pull down potential interaction partners
Proximity ligation assays to visualize protein interactions in situ
FRET/BRET approaches using fluorescently tagged PECR and potential partners
Functional Enzymatic Assays:
Genetic Modulation Approaches:
Structural Biology Integration:
Computational docking studies using known structures
Hydrogen-deuterium exchange mass spectrometry to identify interaction interfaces
Cryo-EM of multi-enzyme complexes if stable associations are suspected
These methodological approaches provide complementary data to build a comprehensive understanding of PECR's role within the larger network of fatty acid metabolism enzymes.
For optimal detection of native PECR in human tissues, the following sample preparation methodology is recommended:
Sample Collection and Processing:
Homogenization Protocol:
Homogenize tissues in buffer containing protease inhibitors
Use gentle mechanical disruption methods to maintain native protein conformation
Consider compartment-specific extraction techniques to enrich for peroxisomal proteins
Centrifugation and Fractionation:
Perform differential centrifugation to separate subcellular fractions
For peroxisome-enriched fractions, use density gradient ultracentrifugation
Verify fraction purity using established peroxisomal markers
Storage Considerations:
Quality Control:
Assess protein integrity by western blotting prior to quantitative assays
Include positive and negative control samples in each experimental batch
Validate detection methods using recombinant PECR standards
These methodical steps ensure optimal preservation of native PECR for subsequent detection and quantification in experimental studies.
Validating the specificity of PECR detection methods requires a multi-step approach:
Positive and Negative Controls:
Antibody Validation for Immunoassays:
ELISA Method Validation:
Gene Expression Verification:
Mass Spectrometry Confirmation:
Perform immunoprecipitation followed by mass spectrometry
Identify PECR-specific peptides using database searching
Quantify using labeled internal standards
These validation steps ensure that experimental observations genuinely reflect PECR biology rather than methodological artifacts or cross-reactivity.
When analyzing PECR expression changes in human tissue samples, selecting appropriate statistical approaches is critical:
Descriptive Statistical Analysis:
Calculate measures of central tendency (mean, median) and dispersion (standard deviation, interquartile range)
Generate box plots or violin plots to visualize distribution of expression levels
Consider normalization to housekeeping genes or total protein for comparative analyses
Inferential Statistics for Group Comparisons:
For normally distributed data: t-tests (paired or unpaired) for two groups; ANOVA for multiple groups
For non-normally distributed data: Mann-Whitney U or Wilcoxon signed-rank tests; Kruskal-Wallis for multiple groups
Include appropriate corrections for multiple comparisons (e.g., Bonferroni, Benjamini-Hochberg)
Advanced Statistical Methods:
Single-Case Experimental Design Analysis:
Data Visualization:
Generate heat maps for multi-tissue comparisons
Use volcano plots to visualize both statistical significance and magnitude of changes
Employ principal component analysis plots for multi-dimensional data
This comprehensive statistical approach ensures robust interpretation of PECR expression data while accounting for biological variability and experimental design considerations.
AI and machine learning approaches offer several advantages for enhancing PECR functional studies:
Big Data Integration:
Natural Language Processing for Literature Mining:
Sentiment and Thematic Analysis for Research Planning:
Efficient Analysis of Large Datasets:
Predictive Modeling:
Machine learning can predict potential PECR interactions, substrate specificities, or functional impacts of genetic variants
These predictions can guide targeted experimental validation, making research more efficient
The integration of human expertise with AI capabilities offers a powerful approach to efficiently analyze complex data while preserving the nuance necessary for meaningful biological interpretation of PECR function .
Translating PECR basic research findings to clinical applications presents several challenges:
Pathway Complexity:
PECR functions within complex metabolic networks, making it difficult to predict the systemic effects of modulating its activity
Compensatory mechanisms may mask phenotypes in experimental models
Comprehensive pathway analysis is required to identify optimal therapeutic targets
Model System Limitations:
Biomarker Development Hurdles:
Therapeutic Development Considerations:
Designing specific modulators of PECR activity without off-target effects
Achieving appropriate drug delivery to peroxisomes
Addressing potential compensatory upregulation of alternative pathways
Clinical Trial Design:
Addressing these challenges requires interdisciplinary collaboration among biochemists, clinicians, and computational biologists to bridge the gap between basic PECR research and clinical applications.
The most promising future directions for PECR human research span multiple dimensions of science and technology:
Integration of Advanced Technologies:
Systems Biology Approaches:
Mapping PECR's place within the broader metabolic network using computational modeling
Identifying regulatory mechanisms and feedback loops involving PECR
Understanding how PECR contributes to metabolic flexibility in different tissues
Translational Research Applications:
Investigating PECR's role in metabolic disorders and potential as a therapeutic target
Developing biomarkers based on PECR activity or metabolite profiles
Creating patient-derived models to study personalized responses to PECR modulation
Methodological Innovations:
The PECR gene encodes a protein that consists of 303 amino acids and has a molecular mass of approximately 33 kDa . The protein contains a C-terminal type I peroxisomal targeting signal (AKL), which is essential for its localization to the peroxisome . The enzyme is a member of the short-chain dehydrogenase/reductase (SDR) family and is highly conserved across species, sharing 71-75% amino acid identity with its homologs in guinea pig and mouse .
PECR is involved in the chain elongation of fatty acids within the peroxisome . It catalyzes the reduction of trans-2-enoyl-CoAs of varying chain lengths, with maximum activity observed with 10:1 CoA . This reduction step is NADPH-specific, meaning that the enzyme uses NADPH as a cofactor to carry out the reduction reaction . The enzyme does not exhibit 2,4-dienoyl-CoA reductase activity .
The activity of PECR is essential for the proper functioning of the peroxisomal fatty acid β-oxidation pathway, which is crucial for the metabolism of very-long-chain fatty acids (VLCFAs) . Disruptions in this pathway can lead to the accumulation of VLCFAs, which are associated with various metabolic disorders .
Recombinant human PECR is used in research to study its enzymatic properties and to develop potential therapeutic interventions . The recombinant form of the enzyme is produced by expressing the PECR gene in suitable host cells, followed by purification of the protein . This allows researchers to investigate the enzyme’s structure, function, and role in various metabolic pathways.